Status:
UNKNOWN
Comparative Study of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Obesity
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
To evaluate and compare the effectiveness of intragastric balloon and Sibutramine (Reductil®) in the treating of non-morbid obese in a randomized controlled manner
Detailed Description
Obesity is a chronic devastating disease and is becoming a major health and socioeconomic issue worldwide. Obesity significantly exacerbates many other chronic illnesses and increases mortality and mo...
Eligibility Criteria
Inclusion
- Age 18-60
- BMI 27-35
- Agree to undergo invasive weight reduction therapy and intensive follow-up
- No history of weight reduction for \>5% of BW for the past 6 months
Exclusion
- Coronary heart disease
- Un-controlled hypertension (160/90 mmHg)
- unstable cardiovascular disease
- unstable cerebrovascular disease
- Renal disease
- Liver disease
- 9\) Diabetes Mellitus 10) Eating disorder 11) Psychiatric illness 12) Pregnant or breast feeding
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00355979
Start Date
March 1 2006
End Date
March 1 2008
Last Update
October 18 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong, Department of Surgery
Hong Kong, Hong Kong, China